Canada Mexico city Baltimore vaccine Health Canada Mexico city Baltimore

Canada, Mexico imported AstraZeneca doses from facility not fully inspected: regulator

Reading now: 936
globalnews.ca

 AstraZeneca‘s COVID-19 vaccine and offered them to the public without health officials properly inspecting the operations of the U.S.

manufacturer, according to inspection records and the regulators involved.The Baltimore plant belonging to Emergent BioSolutions Inc was producing vaccines for both AstraZeneca Plc and Johnson & Johnson under a $628 million U.S.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA